Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Dalfampridine[1] Dalfampridine[1] Dalfampridine 💬[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[2] 4, 13 💬
2Daraprim[1] Pyrimethamine[1] Pyrimethamine 💬--[2] 2, 4 💬
3Dexdor[1] Dexmedetomidine[1] Dexmedetomidine 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[4] 2, 4, 6, 70 💬
4DEXMEDETOMIDINE[1] Dexmedetomidine[1] Dexmedetomidine 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[14] 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
5ESKETAMINE[1] Esketamine[1] Esketamine 💬[5] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		[20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[3] 2, 4, 70 💬
6Ketanest----[3] 2, 4, 70 💬
7Ketanest-S----[3] 2, 4, 70 💬
8Levetiracetam[1] Levetiracetam[1] Levetiracetam 💬[1] SV2A 💬[1] ECM-receptor interaction 💬[5] 2, 4, 6, 13, 307 💬
9PYRIMETHAMINE[1] Pyrimethamine[1] Pyrimethamine 💬--[4] 2, 4, 19, 65 💬
10Stem Cells----[5] 2, 4, 46, 96, 113 💬